Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7–8, 2022

Policymakers often rely on impact and cost-effectiveness evaluations to inform decisions about the introduction of health interventions in low- and middle-income countries (LMICs); however, cost-effectiveness results for the same health intervention can differ by the choice of parameter inputs, mode...

Descripción completa

Detalles Bibliográficos
Autores principales: Fitzpatrick, Meagan C., Laufer, Rachel S., Baral, Ranju, Driscoll, Amanda J., Feikin, Daniel R., Fleming, Jessica A., Jit, Mark, Kim, Sonnie, Koltai, Mihaly, Li, You, Li, Xiao, Nair, Harish, Neuzil, Kathleen M., Pecenka, Clint, Sparrow, Erin, Srikantiah, Padmini, Ortiz, Justin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2023
Materias:
WHO Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680976/
https://www.ncbi.nlm.nih.gov/pubmed/37777450
http://dx.doi.org/10.1016/j.vaccine.2023.09.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680976/
https://www.ncbi.nlm.nih.gov/pubmed/37777450
http://dx.doi.org/10.1016/j.vaccine.2023.09.040

Ejemplares similares